Publication Name	World Journal of Clinical Cases
Manuscript ID	64794
Country	China

Received	2021-03-26 14:03
Peer-Review Started	2021-03-26 14:11
To Make the First Decision
Return for Revision	2021-05-12 10:41
Revised	2021-05-12 14:41
Second Decision	2021-08-23 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-23 07:55
Articles in Press	2021-08-23 07:55
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-11-15 20:21
Typeset the Manuscript	2021-12-08 10:03
Publish the Manuscript Online	2021-12-23 14:14

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Stem cell therapy: A promising treatment for COVID-19
Manuscript Source	Invited Manuscript
All Author List	Zhi-Xue Zheng
ORCID	Author(s) ORCID Number Zhi-Xue Zheng http://orcid.org/0000-0002-4314-9847
Funding Agency and Grant Number
Corresponding Author	Zhi-Xue Zheng, MD, Doctor, Doctor, Surgeon, Surgical Oncologist, Department of General Surgery, Beijing Jishuitan Hospital, No. 31 Xinjiekou East Street, Beijing 100035, China. pollitzheng@sina.com
Key Words	COVID-19; SARS-CoV-2; Mesenchymal stem cells; Pandemic; Stem cell therapy
Core Tip	The coronavirus disease 2019 (COVID-19) has been a global threaten pandemic and entered an emergency phase. But there are still no specific effective drugs for the infection. Many previous studies have been proved that mesenchymal stem cells transplantation was proved to be a promising choice for COVID-19 infected patients, and the further studies need to be done in the future.
Publish Date	2021-12-23 14:14
Citation	Zheng ZX. Stem cell therapy: A promising treatment for COVID-19. World J Clin Cases 2021; 9(36): 11148-11155
URL	https://www.wjgnet.com/2307-8960/full/v9/i36/11148.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i36.11148

Full Article (PDF)	WJCC-9-11148.pdf
Full Article (Word)	WJCC-9-11148.docx
Manuscript File	64794_Auto_Edited-JLW_Kerr C_Clear Copy.docx
Answering Reviewers	64794-Answering reviewers.pdf
Audio Core Tip	64794-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64794-Conflict-of-interest statement.pdf
Copyright License Agreement	64794-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64794-Language certificate.pdf
Peer-review Report	64794-Peer-review(s).pdf
Scientific Misconduct Check	64794-Scientific misconduct check.pdf
Scientific Editor Work List	64794-Scientific editor work list.pdf
CrossCheck Report	64794-CrossCheck report.pdf